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INTRODUCTION
For decades geneticists have understood the interest of studying mutations that, through the genotype they generate, reveal the function of the genes in which they are produced. However, in complex organisms such as the mouse, which is a model of choice for the study of mammals, for many years the hereditary characters: ''Biologists have long attempted by chemical means to induce in higher organisms predictable and specific changes which thereafter could be transmitted in series as hereditary characters''. The aim of our paper is to show how this dream has become reality over the past twenty years, through the development of methods that modify the genetic make-up of the mouse (see Table I ). The creation of mice with genetic modifications programmed by the investigator has revolutionized the study of almost all the biological aspects of this animal and its various systems (immune, nervous, hematopoietic, etc.) (for a review, see Capecchi 1989) . Moreover, this could lead to the creation of murine models for human genetic diseases (Smithies 1993) , precious for studying their physiopathology and eventually for the development of appropriate therapies. As we will see later, this was made possible by the breakthrough of two different approaches: one led to the isolation in vitro of remarkable cells: embryonic stem (ES) cells (Gardner and Brook 1997) ; the other permitted identification, in higher eukaryote cells, of the conditions required for homologous recombination between incoming DNA and the homologous sequence in the chromosome (Smithies et al. 1985, Wong and Capecchi 1986) .
EMBRYONIC STEM CELLS: FABULOUS VEHICLES FOR THE CREATION OF MUTANT MICE
In 1981, two laboratories reported the isolation, from the culture of early mouse embryos, of cell lines with the properties of pluripotent embryonic cells (Martin 1981, Evans and Kaufman 1981) (see Table II ). These cells, called Embryonic Stem (ES) cells, after injection into a young embryo were capable of colonizing all its tissues including the germ line, thus giving birth to chimeras. The ES cell genotype cells could then be ''recycled'' in vivo and transmitted to future generations. Following this, it was demonstrated that these cells could be genetically modified in vitro, by introduction of a transgene, for example, but also that the corresponding transgenic mice could be obtained (Gossler et al. 1986 , Robertson et al. 1986 ) (see Fig. 1 ). Thus a totally new method for obtaining transgenic mice was born, considerably widening the possibility of ''classical'' transgenesis by microinjection of DNA in the zygote. Indeed, it became possible for the investigator to use procedures selecting rare genetic modifications in the ES cells and to obtain the corresponding mutant mice.
HOMOLOGOUS RECOMBINATION IN ES CELLS: CREATION OF ''KNOCK OUT'' MICE
Studies conducted in the eighties, particularly by the groups of Smithies and Capecchi, had demonstrated that mammalian cells have the enzymatic apparatus necessary for recombination between an incoming DNA and the homologous sequence present in situ in the chromosomes, even if this was relatively rare compared with the random integration of this same DNA (Smithies et al. 1985, Wong and Capecchi 1986) . At first, these results were used by these authors to create -or correct -null mutations in the hprt gene (Doetschman et al. 1987, Thomas and Capecchi 1987) : these mutations can be selected directly after transfection of the targeted vector carrying the required mutation, through addition of drugs in the culture medium. Despite the generally variable and low frequency of homologous recombination events, these experiments were later extended to genes the null mutations of which cannot be selected, using various approaches based either on selection or on screening techniques (see Fig. 2 ). Today, hundreds of genes have been invalidated in this manner and corresponding mutant mice have been created (Tbase 2001) . Analysis of the phenotypes generated by these mutations has cast light on the function of the genes concerned. In certain cases, analysis also allowed to reveal the influence of genetic background on the expression of a given mutation (for a review, see Banbury Conference 1997), or to investigate the eventual genetic relationships between genes of the same family (for reviews, see Rudnicki and Jaenisch 1995, Horan et al. 1995) . 
KNOCK-IN
An interesting variation of the targeting vectors for obtaining null mutations can be obtained by the introduction of a given cDNA in frame with the coding sequence of the targeted gene, (Fig. 2) . Following homologous recombination with the chosen target gene, the modified allele expresses the cDNA inserted in replacement of the endogenous gene. The choice of the cDNA obviously depends on the aim of the research. For example, this might be the coding sequence of a reporter gene such as E. coli LacZ gene encoding β-galactosidase, the activity of which is easily traceable even at the single cell level. The expression of β-galactosidase mimics the expression of the targeted gene. This is precious for specifying its expression pattern (Colucci-Guyon et al. 1994) , but can also be useful for monitoring the fate of cells that normally express the targeted gene, in the context of an animal carrying the mutation in the homozygous state (Schneider-Maunoury et al. 1993 , Tajbakhsh et al. 1996 . Another particularly interesting use of the knock-in strategy concerns the genes belonging to a multigenic family, with differing expression patterns, and the invalidation of which leads to contrasting phenotypes. Do the proteins coded by the related genes have equivalent function? A positive reply to this would indicate that the change in expression profile is at the origin of the phenotypes observed and not a differing function of the proteins coded by these genes. According to studies published to date (Table III and Hanks et al. 1995 , Wang and Jaenisch 1997 , Saga 1998 , Acampora et al. 1999 , Geng et al. 1999 , Suda et al. 1999 , it is generally this type of situation that is observed, which underlines the importance of the gene regulating regions acting as targets for evolution and functional diversification.
FROM NULL TO SUBTLE MUTATIONS
If null mutations are a potent instrument in genetic analysis, it is clear that other more subtle types of mutations (point mutations, small deletions or insertions) may also be very useful. On the one hand, they allow to refine the functional analysis of a gene (by changing the amino acid in a particular domain of the protein and observing the effects induced, for example) and on the other hand they also permit creation of murine models of genetic diseases in man: the latter are rarely generated by null mutations (for example, 60% of mutations leading to cystic fibrosis in man are of F 508 type (Kerem et al. 1989 (Fiering et al. 1999) and, in some cases can lead to hypomorph mutations by the introduction the selection sequence in the 5' region of a gene (Meyers et al. 1998) . Several strategies can be used to create what one could call ''clean'' mutations (mutant allele without foreign sequences) (Moore et al. 1998 , for a review see Cohen-Tannoudji and Babinet 1998). We describe two of these in Figure 3 ; however, the one which uses the Cre/loxP system is particularly interesting, because, as we will see, it is versatile over and *This loss is due to the fact that the OTX2 protein appears necessary for the regulation of the expression of the otx2 gene. In Otx1 → Otx2 mutants, the otx2 gene (and therefore the production of the OTX1 protein) is not induced in the anterior neural plaque. E: day of embryonic development.
above obtaining ''clean'' mutations (for a review, see Sauer 1998) . The Cre protein is a recombinase identified in the P1 bacteriophage, which reacts when it recognizes a sequence of 34 base pairs (called loxP) in a segment of DNA (Kilby et al. 1993 ) (see Fig. 4A -B). When two loxP sites are oriented in the same direction, the Cre recombinase induces the deletion of the DNA segment placed between them. Conversely, if the loxP sites are oriented in opposite direction, recombination induces its inversion (see Fig. 4C ). It should be noted that Cre recombinase activity does not require a DNA co- factor or particular topology. Moreover, it is active in the eukaryote cells (Sauer and Henderson 1988) . As is shown in Figure 3 , these properties of the Cre/ loxP system could be used for the creation of alleles carrying ''subtle'' and ''clean'' mutations. At the end of this scenario, the muted allele retains a loxP site; however, no indication of an interference of this site with genetic expression has ever been demonstrated.
DELETIONS VIA TARGETING IN THE ES CELLS: TOWARDS GLOBAL GENETIC ANALYSIS OF THE MOUSE GENOME
Directed mutagenesis via ES cells is, as we have seen, a precious method for analysis of gene function. However this approach is limited to known and cloned genes. In a perspective of global functional analysis of the mouse genome, this inverse genetic approach must be completed by strategies that not only accumulate mutations but also localize them precisely. Thus corresponding genes can eventually be identified and cloned and then be used for targeted mutagenesis.
Over the past fifteen years, highly effective methods of chemical mutagenesis have been obtained which result in high-rate and random introduction of mutations in the mouse genome: the use of N-ethyl-N-nitrosourea (ENU) (Bode 1984) , for a review, see Brown and Peters 1996) , a potent mutagenic agent, leads, in the male mouse, to a mutation in a given gene in one gamete out of 700 (which is equivalent to a per locus mutation of around 1.5 x 10 -3 and is very high). In general, the effect of ENU results in the creation of point mutations. Once the males have been treated by ENU and therefore carry mutations in their spermatogonia, an approach is needed to identify and collect these mutations. This would be made easier, in the case of recessive mutations, if one disposed of discrete deletions throughout the genome: the crossing between mice carrying a deletion in a given region and those carrying mutations induced by ENU should facilitate, the localization and the identification of the gene(s) responsible for the phenotype obtained, due to functional haploidy of the deleted region. This type of scenario, the interest of which has been clearly demonstrated in Drosophila, is difficult to apply to the mouse because of the relative rarity of deletions reported in this animal. In this context, targeting by homologous recombination in ES cells combined with the properties of the Cre/loxP system opens new opportunities ( for a review, see Justice et al. 1997 ) (Fig. 4C-D) . This strategy was validated in 1995 when mice carrying deletions of several centimorgans (cM) were obtained (Ramirez-Solis et al. 1995) . Using a different scenario, You et al. (1997) obtained deletions of varying length around a given locus. In the future, a collection of deletions could be accumulated and used, in combination with ENU mutagenesis, for long-term projects of global functional analysis of the mouse genome. The constant extension of genetic maps of the mouse and man should permit to analyse more specifically genomic regions which would be rich in genes and/or thought to be candidates for human genetic diseases.
CHROMOSOMAL REARRANGEMENTS MADE EASIER BY THE EXPRESSION OF CRE IN THE MALE GERM LINE
The recent generation of transgenic mice expressing Cre in the male germ line has simplified the process permitting the creation of chromosomal rearrangements in the mouse, by conducting part of the operations directly in vivo. Indeed, transgenic mice with an Sycp1-Cre fusion gene (in which the regulatory sequences of Sypc1 coding for protein 1 of the synaptosomal complex control Cre protein expression), express the Cre protein in a specific manner during the pro-phase of the first meiotic division of male germ line cells, at a time when the chromosomal pairing starts and crossing-over is therefore facilitated (Vidal et al. 1998) . If one crosses mice carrying loxP sites on chromosomes homologous with the latter, one obtains, in double-transgenic males issued from this crossing, spermatozoa containing deletions or duplications of the genomic region situated between the loxP sites ( Figure 4D ). Potentially, this approach is a strong tool for the functional analysis of complex genomic regions: for example, the question of functional significance of the clustering of Hox genes into complexes can be determined by varying their number or their position in these complexes (Herault et al. 1998 ).
CONDITIONAL MUTAGENESIS: A NEW DIMENSION OF FUNCTIONAL GENOME ANALYSIS
a) The Cre/loxP system: targeting of Cre by a fusion transgene
We have emphasized the interest for the functional analysis of the genome of programmed creation of mice carrying various genetic modifications (null mutations, discrete mutations, chromosomal rearrangements, etc). However, these situations in which mutated mice carry the mutation in all their cells have their limitations in particular for two reasons: (1) in cases in which the mutation provokes embryonic lethality in the homozygous state (an ex-treme case is when mutation leads to cell death), it is impossible to study the eventual function of the gene beyond the time of embryonic letality and consequently during adulthood; (2) a gene may have a wide expression and its invalidation provoke a complex phenotype affecting multiple tissues. To simplify analysis in this case it would be interesting to create mice expressing the mutation in only one or the other of these tissues.
In an effort to overcome these limitations of programmed mutagenesis in vivo, in recent years different teams tried to develop strategies in which the expression of a mutation would be rendered conditional (for a review, see Gu et al. 1994, CohenTannoudji and . These strategies are based on the remarkable properties of the Cre/loxP system. The first step (see Fig. 5 ) consists in creating mice carrying alleles in which two loxP sites surround an essential part of the gene to be studied, without disrupting its activity, by placing them for example in the introns (we subsequently call these alleles ''floxed'' alleles). In the case of a gene whose null mutations are letal in the homozygous state, it is necesssary to verify that the mice homozygous for the floxed allele are viable. These mice are then crossed with a transgenic mouse expressing the Cre recombinase in a particular cell type, using appropriate regulatory sequences in the transgene (the Cre recombinase promotes the deletion of the sequences located between the loxP sites and induces a null mutation in the cell type in which the transgene is expressed). This strategy is powerful since it not only avoids the embryonic lethality produced when all the embryo cells carry the mutation, but also allows to address the effect of this mutation in any tissue, so long as a line of transgenic mice expressing protein Cre in the tissue concerned is available (Table IV, Tsien et al. 1996 , Shibata et al. 1997 , Harada et al. 1999 , Kulkarni et al. 1999 , Xu et al. 1999 ).
b) Inducible systems
Supplementary refinement consists in controlling induction of the mutation, not only in space as explained above but also in time. To that end" protein Cre is expressed in the form of a fusion protein with the ligand binding domain of a steroid receptor (LBD) (Kellendonk et al. 1996 , Feil et al. 1996 ; this fusion protein has no Cre activity (see Fig. 6 ). However, in the presence of an appropriate ligand, a change in conformation is produced that restores Cre activity. Thus, in transgenic mice carrying the two floxed alleles of the gene concerned and the transgene expressing the fusion protein LBD/Cre under the control a promoter functioning in a given tissue, induction of a null mutation can be obtained by injection, at a given time, of the appropriate ligand (Fig.  6 ). An interesting alternative to the use of LBD/Cre fusion proteins was recently demonstrated by the injection, in a tissue of a mouse carrying the ''floxed'' gene, of an adenoviral vector capable of expressing Cre: indeed, only the cells infected locally by the virus expressed the mutation (Table IV and Shibata et al. 1997) . To end our brief description of the approaches developed to obtain conditional mutations, one must mention the possibility of controlling the recombinase expression by using systems that induce or inhibit the transcription of a reporter gene. The most documented system uses the operator/repressor properties of the bacterial operon, tetracycline (tet) (Baron et al. 1999 ). This comprises on the one hand a reporter gene controlled by a minimal promoter linked to a concatermer of the tet operator (tetO) sequences, and on the other hand a gene expressing a fusion protein between the repressor tetR and the activation domain of the VP16 protein (protein tTA). In the presence of tetracycline the fusion protein cannot bind to the tetO sequences and the reporter gene is not expressed. In the absence of tetracycline, the fusion protein can bind and the reporter gene is expressed. An alternative is to use a fusion protein constructed with a mutant version of the tetR repressor which can only bind to the tetO sequences in the presence of tetracycline: activation of the reporter gene can therefore be induced by addition of the antibiotic. The proof of the transcriptional control obtained using this binary system has been demonstrated in cell cultures and in transgenic ←− Fig. 4 -The Cre/loxP system and its applications. The loxP site, symbolized by a triangle is a sequence of 34 base pairs composed of palindromic sequences of 13 pb separated by a sequence of 8 pb (A). Cre recombinase specifically recognizes this sequence, provokes the cleavage in DNA (vertical arrows, A) and induces the recombination of DNA between the two loxP sites as illustrated in B. This reaction is reversible. Several types of recombination events can be produced depending on whether the two loxP sites are carried by the same DNA molecule (recombination in cis) or by two different DNA molecules (recombination in trans) and depending on the respective orientation of the two loxP sites (the orientation of a loxP is given by the non-palindromic 8 pb sequence). Recombination in cis (C). If the two loxP sites have the same orientation, the DNA region situated between these sites is deleted during recombination.
This type of configuration is used to create ''clean'' mutations (elimination of the selection cassette, see Fig. 3 ), conditional mutations (see Fig. 5 ) and deletions. If the orientation of the two loxP sites is opposed, recombination leads to the inversion of the region comprised between the two sites. Recombination in trans (D). If one loxP site is integrated in the genome and the other is carried by a circular plasmid, there may be an insertion of sequences carried by the plasmid in the integrated loxP site. However, since the insertion is a rare event compared to deletion (i.e., the reverse reaction), this type of event requires the use of mutant loxP sites (see Conclusions/Perspectives). When the loxP sites are both integrated in the genome, recombination in trans induces chromosomal rearrangements: deletions, duplications or translocations. Such recombination events are rare and have to be selected to be revealed.
To do so, one can use truncated and non-functional hp-loxP and loxP-rt selection cassettes. After recombination between the loxP sites, and only in this case, a functional hp-loxP-rt cassette (the remaining loxP site is situated in an intron) is reconstituted, thus allowing selection of the chromosomal rearrangement desired. Furthermore, the relative orientation of loxP sites compared with the centromeric telomeric axis of the chromosomes is important. Indeed, in the case of wrong relative orientation, recombination will result in the formation of acentric or dicentric chromosomes, which, in view of their great instability, will be eliminated from the cell.
mice. This strategy could therefore be used for the temporal and spatial control of the expression of Cre (Utomo et al. 1999) . For various reasons, the conditional mutagenesis strategies that we have briefly described may prove difficult to use. However they are of invaluable interest in thorough gene function analysis and many teams are conducting research to improve the different steps. Two conditions are mandatory to avoid any bias in results and their interpretation: (1) the total cell population in which one wants to measure the impact of the mutation must express protein Cre; (2) expression of protein Cre must be strictly controlled and limited to the population concerned. These conditions are difficult to fulfill, in particular because expression of protein Cre is generally obtained by the creation of conventional transgenic mice (through microinjection into the zygote) in which the transgene is integrated at random; however, it is well established that transgene expression depends on its site of insertion and therefore may be perturbed or even lost. This can be circumvented by inserting, via ''Knock-in'' (see above), Cre coding sequences in a gene with specific expression corresponding to the cell types in which the investigator wishes to induce the mutation (Rickert et al. 1997 , Harada et al. 1999 .
CONCLUSION/PERSPECTIVES
If we look at the present state of programmed mutagenesis in vivo in the mouse, several reflections come to mind as regards the ways to circumvent the present difficulties and the possible developments. 1) First, it is important to note that among the mammalians studied, programmed modification of the germ line is only accessible in laboratory mice. Indeed, until now, it has been impossible, despite multiple attempts, to isolate ES type cells capable of colonizing the germ line in other laboratory or farm mammals. A special mention should be made about the human species. Indeed, three different groups (Thomson et al. 1998 , Shamblott et al. 1998 have recently reported the isolation of human pluripotent embryonic stem cells. In two cases, these cells were isolated from blastocysts, The other is a transgenic mouse expressing the Cre recombination under the control of a given promoter. If this promoter directs the expression of Cre in the female germ line (strain C), the animals issued from a cross between a female C and a male A will carry the deletion in all their cells, the recombination event having taken place at the zygote stage through the recombinase accumulated in the oocyte. If the promoter directs the expression of Cre in one or several cell types (strain B), the animals born from a cross between a mouse A and a mouse C will be mosaics: the cell types expressing the recombinase will carry a deleted allele whereas the other cells of the animal will carry a ''floxed'' allele. CNS: central nervous system; P: promoter.
in the third case, the pluripotent cells were generated taking a different route in which germ cells from foetal gonads were used as a starting material (these cells are therefore called Embryonic Germ (EG) cells). Although it was not possible to test their ability to contribute to the germ line, the human ES cells share with those of the mouse other key features of embryonic stem cells, i.e., unlimited self-renewal, normal caryotype, ability to differentiate into cell types of the three germ layers. However, there remain several problems to be solved before they can be used in such a versatile way as is the case with mouse ES cells. These difficulties pertain, in particular, to the very limited knowledge of the factor(s) which control and maintain the undifferentiated state and to the fact that they exhibit a poor ability to grow clonally. Despite these limitations, which should be overcome in the near future, the availability of human ES cells opens new and very interesting possibilities both for a better understanding of human embryonic development and for ES cell based therapies (for a review, see Pera et al. 2000) .
A recent study illustrates a possible means, though experimentally demanding, to perform programmed genetic modifications in absence of bona fide ES cells; it is based on the advent of methods allowing cloning of several mammalian species by the transfer of nuclei from embryonic and even adult nuclei into oocytes (sheep, cow, mouse and and most recently pig) (for a review, see (Solter 2000) . Indeed, McCreath et al. (2000) targeted the ovine α1 (I) procollagen gene in sheep fetal fibroblasts and could reconstitute a whole animal by the transfer of a nucleus carrying the genetic modification into an enucleated oocyte. Despite its fairly low rate of success (about 1% of the reconstructed embryos give rise to live and apparently normal offspring), these results represent a breakthrough and demonstrate the feasability of obtaining gene targeted animals in mammals by nuclear transfer.
2) We have emphasized the obvious interest of obtaining, via programmed ES cell mutagenesis, mutants for the study of various biological problems. However two other aspects of ES cells should be underlined. The first pertains to the ability of ES cells to undergo differentiation in vitro. Over recent years, a number of teams have tried to develop experimental conditions permitting orientation of this differentiation towards a given lineage (muscle, hematopoietic, nerve cells, etc.) (Brustle et al. 1999 , for a review see Keller 1995) . Once these systems have been developed, introduction in ES cells of the gene mutations eventually implied in a given differentiation pathway and should bring new light on their function. Secondly, certain aspects of the phenotype engendered by a given genetic modification (null mutation in the homozygous state, dominant negative allele) can be further defined by the creation of chimeras between the genetically modified ES cells and wildtype embryos (Rossant et al. 1998) . This type of analysis allows, in particular, to determine whether a mutation is cell autonomous or not.
3) From a methodological point of view, despite the wide use of programmed mutagenesis in the mouse, it should be noted that it remains difficult and expensive not only in time but also in terms of budget. From this point of view, the development of new scenarios should in the long-term ensure that the creation of mutations is less costly and more efficient. These scenarios profit essentially from the existence of enzymatic systems that play a role in the recombination process. One of them is the Cre/loxP system that has been largely presented above. Thus, it would be valuable to try and take advantage of the integration event catalyzed by the Cre recombinase, resulting in the integration of a circular DNA carrying a loxP site in a genomic location of interest also carrying a loxP site (Fig. 4D) . Normally it is the reverse reaction (intramolecular deletion) that is privileged. However some ''tricks'' (based on the use of mutant loxP sites) allow to enhance the insertion reaction (Araki et al. 1997) . Another approach relies on the observation of robust stimulation of recombination following double-strands DNA breaks. These can be promoted by using a meganuclease, I-SceI, isolated from yeast, which recognizes a specific 18 bp site. Once an allele of a given gene carrying an I-SceI site has been created (by homologous recombination in ES cells), varying genetic modifications could be introduced repeatedly and efficiently by co-transfection of an expression vector for I-SceI, promoting a double-strand break, together with a repair vector permitting the introduction of the desired modification (Donoho et al. 1998 . Such approaches may ultimately permit programmed mutagenesis directly in ovo, which would represent an obvious simplification. 4) Despite the interest of targeted mutagenesis that we have underlined in this article, it remains a quite laborious and step by step process: cloning of the gene considered, construction of appropriate vectors, selection and identification of targeted cells and derivation of the corresponding mutant mice. More than 1500 genes have now been processed in this manner, which is a minority compared with the 30 to 40 000 genes contained by the genome of the mouse or man. Sequencing programs will provide these genes, till we reach complete sequencing of the mouse genome which should soon happen. There would be great interest in developing tools permitting the mutation of any gene, while circumventing the cloning phase. As far as this is concerned, an approach is being developed, based on a gene trap strategy strategy in ES cells using a trapping vector which in principle traps any gene, whether expressed or not (Zambrowicz et al. 1998) .Thus, a library of ES cells is available, carrying tagged genes. However, this approach has its own limitations: the type of mutation is stereotyped (insertion) and insertion of the trapping vector does not lead to total invalidation in all cases. In conclusion, it is clear that homologous recombination in ES cells of the mouse has met its expectations. Creation of widely varying types of mutations, affecting either a gene or whole genomic regions continues to supply invaluable information on the function of genes and the genome in the physiology and biology of the mouse while providing murine models of human diseases. The recent methodological developments, based on the use of proteins that intervene in the recombination process, will obviously widen these possibilities not only qualitatively but also quantitatively. Palavras-chave: células-tronco embrionárias, genoma, mira genética, camundongos ''knock out'', mutações condicionais.
